H3K27me3与Ki-67标记指数在评估脑膜瘤生物学行为中的作用
研究纳入81例脑膜瘤(含11例复发),用免疫组化评估Ki-67指数(<5%、5%-10%、>10%)与H3K27me3表达(阴性0、低1-4、高5-9)。结果显示1级脑膜瘤中出现坏死和明显核仁等非典型形态特征及H3K27me3低表达与更高分级、复发和更短无进展生存显著相关;Ki-67指数升高与复发和不良预后相关。作者认为二者可作为脑膜瘤预后标志物,尤其用于困难的1、2级和复发病例。
要点
- 1级脑膜瘤伴坏死和明显核仁等非典型形态特征及H3K27me3低表达与更高分级、复发和更短无进展生存显著相关。
- Ki-67指数升高与脑膜瘤复发和不良预后相关。
- H3K27me3与Ki-67指数可能作为脑膜瘤预后标志物,尤其用于1、2级和复发病例。
核心结论
- H3K27me3与Ki-67标记指数对评估脑膜瘤生物学行为具有重要性,尤其有助于判断困难的1级、2级和复发病例的预后。
- 作者强调需要进一步研究验证这些标志物并开发靶向治疗策略。
研究设计与样本
- 经机构伦理委员会批准后,研究纳入81例脑膜瘤病例,其中11例为复发病例。
- 采用免疫组化评估Ki-67指数和H3K27me3表达。
- Ki-67标记指数按阳性MIB-1细胞计数分为<5%、5%-10%和>10%三类。
- H3K27me3表达按阳性肿瘤细胞比例与染色强度的乘积评估,分为阴性(0)、低表达(1-4)和高表达(5-9)。
主要发现
- 1级脑膜瘤中出现坏死和明显核仁等非典型形态特征及H3K27me3低表达与更高分级、复发和更短无进展生存显著相关,Kaplan-Meier曲线显示更高的阴性斜率。
- 较高的Ki-67标记指数与复发和不良预后相关。
临床怎么用
- 作者认为H3K27me3和Ki-67标记指数可作为脑膜瘤的有用预后标志物,尤其用于困难的1级和2级病例及复发性脑膜瘤。
- 原文未据此给出具体临床推荐。
局限性
- 原文在结论中强调需要进一步研究来验证这些标志物并开发靶向治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Meningiomas are neoplasms primarily originating from arachnoid cells and are classified into 3 grades (1, 2, and 3) based on histological features according to the World Health Organization classification. However, this classification system is imperfect especially for grade 1 and 2 meningiomas as many grade 1 tumors recur. Meningiomas are hence a histologically diverse class of tumors exhibiting more unpredictable behavior. Therefore, more improved classification is required, possibly using novel and more dependable biomarkers. In this study, we aim to investigate the role of the H3K27me3 and Ki-67 labeling index (LI) in assessing the biological behavior of meningiomas. The study was conceived, with the primary objective of examining the expression of H3K27me3 and Ki-67 LI in grade 1/2 meningiomas with atypical features to ascertain if this potentially impacts patient prognosis. METHODS: Upon obtaining clearance from the Institutional Ethical Committee, the authors studied 81 cases of meningiomas including 11 recurrent cases. The study used immunohistochemistry to evaluate the Ki-67 index and H3K27me3 immunohistochemistry. The Ki-67 LI was determined by counting the positively stained MIB-1 cells and categorizing them into <5%, 5%-10%, and >10%. The H3K27me3 staining was evaluated by finding the product of the tumor cells showing positive staining and the intensity of staining. Based on the product of the two, the cases were subdivided into negative (0), low (1-4), and high expression (5-9) of H3K27me3. RESULTS: The results showed that the presence of atypical morphological features including necrosis and prominent nucleoli in grade 1 meningioma and low expression of H3K27me3 was significantly associated with higher grade, recurrence, and shorter progression-free survival (Kaplan-Meier curves showed higher negative slope). The study also found that a higher Ki-67 LI was associated with recurrence and poor prognosis. This suggests that the H3K27me3 and Ki-67 LI can be useful prognostic markers in meningiomas, particularly in challenging grade 1 and 2 cases and recurrent meningiomas. CONCLUSIONS: The study highlights the importance of the H3K27me3 and Ki-67 LI in assessing the biological behavior of meningiomas. The findings provide valuable insights into the prognosis and treatment of meningiomas, emphasizing the need for further research to validate these markers and develop targeted therapeutic strategies.
引用
- Deshpande S, Nayal B, Nair R, et al. Role of H3K27me3 and Ki-67 Labeling Index in Assessing the Biological Behavior of Meningiomas. World Neurosurg. 2024. PMID: 39608490. doi:10.1016/j.wneu.2024.11.097
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。